Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.

Yoshimura M, Moriwaki K, Noto S, Takiguchi T.

Osteoporos Int. 2017 Feb;28(2):643-652. doi: 10.1007/s00198-016-3782-5. Epub 2016 Oct 14.

PMID:
27743068
2.

Diffusion Tensor Imaging Tractography in Pure Neuritic Leprosy: First Experience Report and Review of the Literature.

Colonna MR, Tallarida G, d'Alcontres FS, Noto S, Parodi A, Tagliafico A.

Case Rep Neurol Med. 2016;2016:2767856. Epub 2016 Sep 21.

3.

Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.

Moriwaki K, Noto S.

Osteoporos Int. 2017 Feb;28(2):621-632. doi: 10.1007/s00198-016-3777-2. Epub 2016 Oct 4.

PMID:
27699441
4.

Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.

Shiroiwa T, Ikeda S, Noto S, Igarashi A, Fukuda T, Saito S, Shimozuma K.

Value Health. 2016 Jul-Aug;19(5):648-54. doi: 10.1016/j.jval.2016.03.1834. Epub 2016 Apr 26.

5.

Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.

Shiroiwa T, Saito S, Shimozuma K, Kodama S, Noto S, Fukuda T.

Appl Health Econ Health Policy. 2016 Jun;14(3):375-85. doi: 10.1007/s40258-016-0236-3.

PMID:
26940671
6.

Gamma Heavy Chain Disease with T-cell Large Granular Lymphocytic Leukemia: A Case Report and Review of the Literature.

Iijima M, Sekiguchi N, Nagata A, Wagatsuma M, Midorikawa K, Kurimoto M, Noto S, Yamada K, Takezako N.

Intern Med. 2016;55(4):399-403. doi: 10.2169/internalmedicine.55.5042. Epub 2016 Feb 15. Review.

7.

Epidemiologic trends of leprosy for the 21st century.

Schreuder PA, Noto S, Richardus JH.

Clin Dermatol. 2016 Jan-Feb;34(1):24-31. doi: 10.1016/j.clindermatol.2015.11.001. Epub 2015 Nov 4.

PMID:
26773620
8.

[Achievement of deep molecular response in an elderly chronic myeloid leukemia patient intolerant to imatinib and nilotinib].

Kurimoto M, Nagata A, Sekiguchi N, Noto S, Takezako N.

Rinsho Ketsueki. 2015 Dec;56(12):2467-71. doi: 10.11406/rinketsu.56.2467. Japanese.

PMID:
26725357
9.

Japanese Population Norms for Preference-Based Measures: Eq-5d-3l, Eq-5d-5l, And Sf-6d.

Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K.

Value Health. 2015 Nov;18(7):A738. doi: 10.1016/j.jval.2015.09.2830. Epub 2015 Oct 20. No abstract available.

10.

Validation of Fracture Risk Model In Japanese Women Compared With Frax.

Moriwaki K, Noto S.

Value Health. 2015 Nov;18(7):A698. doi: 10.1016/j.jval.2015.09.2606. Epub 2015 Oct 20. No abstract available.

11.

Comparison Between The Interim Eq-5d-5l Score And The New Japanese Scoring In Stroke Patients.

Noto S, Izumi R, Shiroiwa T, Igarashi A, Ikeda S, Fukuda T, Saito S, Shimozuma K, Kobayashi M, Moriwaki K, Ishida H.

Value Health. 2015 Nov;18(7):A397. doi: 10.1016/j.jval.2015.09.903. Epub 2015 Oct 20. No abstract available.

12.

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.

Shiroiwa T, Fukuda T, Ikeda S, Igarashi A, Noto S, Saito S, Shimozuma K.

Qual Life Res. 2016 Mar;25(3):707-19. doi: 10.1007/s11136-015-1108-2. Epub 2015 Aug 25.

13.

Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy.

Takezako N, Sekiguchi N, Nagata A, Homma C, Takezako Y, Noto S, Natori K, Miwa A.

Thromb Res. 2015 Jul;136(1):20-3. doi: 10.1016/j.thromres.2015.03.029. Epub 2015 Apr 10.

PMID:
25934464
14.

Enlarging ulcers in the mouth and on the back. Granulomatosis with polyangiitis.

Massone C, Felletti R, Noto S, Pelucco D, Bandelloni R, Barabino G.

Am J Dermatopathol. 2015 Apr;37(4):293-4, 341-2. doi: 10.1097/DAD.0b013e318261ea1d. No abstract available.

PMID:
25794370
15.

Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients.

Nagata A, Sekiguchi N, Kurimoto M, Noto S, Takezako N.

Int J Hematol. 2015 Mar;101(3):268-72. doi: 10.1007/s12185-015-1737-9. Epub 2015 Jan 28.

PMID:
25628102
16.

Long-Term Grading of Health-Related Quality of Life of Care-Needed Elderly: A 2-Yr Follow-Up Study.

Noto S, Izumi R, Moriwaki K.

Value Health. 2014 Nov;17(7):A514. doi: 10.1016/j.jval.2014.08.1587. Epub 2014 Oct 26. No abstract available.

17.

A Comparison of Value for Health States Worse Than Dead Between Japan and Uk.

Noto S, Shimozuma K, Saito S, Shiroiwa T, Fukuda T, Moriwaki K, Izumi R.

Value Health. 2014 Nov;17(7):A514. doi: 10.1016/j.jval.2014.08.1585. Epub 2014 Oct 26. No abstract available.

18.

Cost-Effectiveness of Multiple Anti-Osteoporotic Therapies for Secondary Fracture Prevention in Japan.

Moriwaki K, Yoshimura M, Izumi R, Noto S.

Value Health. 2014 Nov;17(7):A381. doi: 10.1016/j.jval.2014.08.2620. Epub 2014 Oct 26. No abstract available.

19.

Health Economic Evaluation of Osteoporosis Screening and Treatment Strategy in the Elderly Japanese Women.

Yoshimura M, Moriwaki K, Noto S, Takiguchi T.

Value Health. 2014 Nov;17(7):A380. doi: 10.1016/j.jval.2014.08.2613. Epub 2014 Oct 26. No abstract available.

20.

Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.

Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Sakamoto K, Kawamura K, Ishihara Y, Sato M, Ashizawa M, Terasako-Saito K, Kimura S, Yamazaki R, Kako S, Kanda J, Nishida J, Sekiguchi N, Noto S, Kida M, Hangaishi A, Usuki K, Kanda Y.

J Chemother. 2015 Feb;27(2):99-105. doi: 10.1179/1973947814Y.0000000219. Epub 2014 Oct 14.

PMID:
25314911

Supplemental Content

Support Center